創傷和急診醫學科
止血的管理和優化
抗纖溶藥物
Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (開啟新視窗)
來源: World J Emerg Surg 2024;19(1):26.
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. (開啟新視窗)
來源: Lancet 2019;394(10210):1713-23.
Alternatives to allogeneic platelet transfusion. (開啟新視窗)
來源: Br J Haematol 2016;175(3):381-92.
Antifibrinolytic drugs for acute traumatic injury. (開啟新視窗)
來源: Cochrane Database Syst Rev 2015;(5):CD004896.
Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. (開啟新視窗)
來源: JAMA Surg 2013;148(3):218-25.
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (開啟新視窗)
來源: Lancet 2011;377(9771):1096-101, 1101.e1-2.
重組活化凝血因子VII(rFVIIa)
Efficacy of recombinant activated Factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis. (開啟新視窗)
來源: Transfusion 2009;49(3):570-7.
The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (開啟新視窗)
來源: Transfusion 2009;49 Suppl 5:240S-7S.
凝血因子濃縮劑
去氨加壓素
Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (開啟新視窗)
來源: World J Emerg Surg 2024;19(1):26.
Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury. (開啟新視窗)
來源: J Trauma Acute Care Surg 2020;88(1):80-6.
利用血液粘彈性檢測辨別外科性出血或凝血病出血
Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. (開啟新視窗)
來源: Acta Anaesthesiol Scand 2010;54(1):111-7.
